Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Malarone weekly dosing for malaria prophylaxis
NCT00984256Phase 2Completed
- Sponsor
- U.S. Army Medical Research and Development Command
- Start
- Sep 2009
- Primary completion
- Apr 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of atovaquone + proguanil in malaria, sponsored by U.S. Army Medical Research and Development Command. Started Sep 2009; status: completed.
02
Drugs
atovaquone + proguanil
03
Conditions
malaria
Beyond the preview
Go deeper on NCT00984256.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00984256.